EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 30 / No 10 (Octobre 2014) Med Sci (Paris), 30 10 (2014) 874-881 References
Free Access
Issue
Med Sci (Paris)
Volume 30, Number 10, Octobre 2014
Page(s) 874 - 881
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20143010014
Published online 14 October 2014
  1. Caligiuri G. Rôle de l’immunité dans l’athérosclérose et dans les syndromes coronariens aigus. Med Sci (Paris) 2004 ; 20 : 175–181. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Anderson GF, Chu E. Expanding priorities. Confronting chronic disease in countries with low income. N Engl J Med 2007 ; 356 : 209–211. [CrossRef] [PubMed] [Google Scholar]
  3. Emmerich J. L’athérosclérose. Collection Pathologie Science, Paris : John Libbey Eurotext, 2000. [Google Scholar]
  4. Chisolm GM, Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 2000 ; 28 : 1815–1826. [CrossRef] [PubMed] [Google Scholar]
  5. Campbell KA, Lipinski MJ, Doran AC, et al. Lymphocytes and the adventitial immune response in atherosclerosis. Circ Res 2012 ; 110 : 889–900. [CrossRef] [PubMed] [Google Scholar]
  6. Hamze M, Desmetz C, Guglielmi P. B cell-derived cytokines in disease. Eur Cytokine Netw 2013 ; 24 : 20–26. [PubMed] [Google Scholar]
  7. De Jager SCA, Kuiper J. Vaccination strategies in atherosclerosis. Thromb Haemost 2011 ; 106 : 796–803. [CrossRef] [PubMed] [Google Scholar]
  8. Caligiuri G, Nicoletti A, Poirier B, Hansson GK. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest 2002 ; 109 : 745–753. [CrossRef] [PubMed] [Google Scholar]
  9. Major AS, Fazio S, Linton MF. B-Lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 2002 ; 22 : 1892–1898. [CrossRef] [PubMed] [Google Scholar]
  10. Ait-Oufella H, Herbin O, Bouaziz JD, et al. B cell depletion reduces the development of atherosclerosis in mice. J Exp Med 2010 ; 207 : 1579–1587. [CrossRef] [PubMed] [Google Scholar]
  11. Kyaw T, Tay C, Khan A, et al. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J Immunol 2010 ; 185 : 4410–4419. [CrossRef] [PubMed] [Google Scholar]
  12. Ponnuswamy P, Van Vre EA, Mallat Z, Tedgui A. Humoral and cellular immune responses in atherosclerosis: spotlight on B- and T-cells. Vascul Pharmacol 2012 ; 56 : 193–203. [CrossRef] [PubMed] [Google Scholar]
  13. Mironova M, Virella G, Lopes-Virella MF. Isolation and characterization of human antioxidized LDL autoantibodies. Arterioscler Thromb Vasc Biol 1996 ; 16 : 222–229. [CrossRef] [PubMed] [Google Scholar]
  14. Kyaw T, Tipping P, Toh BH, Bobik A. Current understanding of the role of B cell subsets and intimal and adventitial B cells in atherosclerosis. Curr Opin Lipidol 2011 ; 22 : 373–379. [CrossRef] [PubMed] [Google Scholar]
  15. Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006 ; 6 : 205–217. [CrossRef] [PubMed] [Google Scholar]
  16. Lusis AJ. Atherosclerosis. Nature 2000 ; 407 : 233–241. [CrossRef] [PubMed] [Google Scholar]
  17. Doran AC, Lipinski MJ, Oldham SN, et al. B-cell aortic homing and atheroprotection depend on Id3. Circ Res 2012 ; 110 : e1–e12. [CrossRef] [PubMed] [Google Scholar]
  18. Hamze M, Desmetz C, Berthe ML, et al. Characterization of resident B cells of vascular walls in human atherosclerotic patients. J Immunol 2013 ; 191 : 3006–3016. [CrossRef] [PubMed] [Google Scholar]
  19. Burioni R, Canducci F, Saita D, et al. Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques. J Immunol 2009 ; 183 : 2537–2544. [CrossRef] [PubMed] [Google Scholar]
  20. Kyaw T, Tipping P, Bobik A, Toh BH. Protective role of natural IgM-producing B1a cells in atherosclerosis. Trends Cardiovasc Med 2012 ; 22 : 48–53. [CrossRef] [PubMed] [Google Scholar]
  21. Lewis MJ, Malik TH, Ehrenstein MR, et al. Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient lice. Circulation 2009 ; 120 : 417–426. [CrossRef] [PubMed] [Google Scholar]
  22. Perry HM, Bender TP, McNamara CA. B cell subsets in atherosclerosis. Front Immunol 2012 ; 3 : 373. [CrossRef] [PubMed] [Google Scholar]
  23. Allan LL, Hoefl K, Zheng DJ, et al. Apolipoprotein-mediated lipid antigen presentation in B cells provides a pathway for innate help by NKT cells. Blood 2009 ; 114 : 2411–2416. [CrossRef] [PubMed] [Google Scholar]
  24. Palinski W, Tangirala RK, Miller E, et al. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb Vasc Biol 1995 ; 15 : 1569–1576. [CrossRef] [PubMed] [Google Scholar]
  25. Klimov AN, Denisenko AD, Vinogradov AG, et al. Accumulation of cholesteryl esters in macrophages incubated with human lipoprotein-antibody autoimmune complex. Atherosclerosis 1988 ; 74 : 41–46. [CrossRef] [PubMed] [Google Scholar]
  26. Nicoletti A, Paulsson G, Caligiuri G, et al. Induction of neonatal tolerance to oxidized lipoprotein reduces atherosclerosis tn ApoE knockout mice. Mol Med 2000 ; 6 : 283–290. [PubMed] [Google Scholar]
  27. Zhou XH, Caligiuri G, Hamsten A, et al. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler Thromb Vasc Biol 2001 ; 21 : 108–114. [CrossRef] [PubMed] [Google Scholar]
  28. Hernandez-Vargas P, Ortiz-Munoz G, Lopez-Franco O, et al. Fc gamma receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice. Circ Res 2006 ; 99 : 1188–1196. [CrossRef] [PubMed] [Google Scholar]
  29. Mendez-Fernandez YV, Stevenson BG, Diehl CJ, et al. The inhibitory Fc gamma RIIb modulates the inflammatory response and influences atherosclerosis in male apoE-/- mice. Atherosclerosis 2011 ; 214 : 73–80. [CrossRef] [PubMed] [Google Scholar]
  30. Galkina E, Kadl A, Sanders J, et al. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J Exp Med 2006 ; 203 : 1273–1282. [CrossRef] [PubMed] [Google Scholar]
  31. Varthaman A, Khallou-Laschet J, Thaunat O, et al. L’athérogenèse : une maladie dysimmunitaire. Med Sci (Paris) 2008 ; 24 : 169–176. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  32. Bouaziz JD, de Masson A, Le Buanec H, et al. Lymphocytes B régulateurs : état des connaissances. Med Sci (Paris) 2014 ; 30 : 721–724. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  33. Catalan N, Imai K, Revy P, et al. Deux ans après, l’activation induced cytidine deaminase n’a pas livré tous ses secrets. Med Sci (Paris) 2003 ; 19 : 139–141. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  34. Cartron G, Rossi JF. Anticorps monoclonaux thérapeutiques en oncohématologie. Med Sci (Paris) 2009 ; 25 : 1085–1089. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.